Skip to content

Different Medications to Induce Labor

Misoprostol Versus Pitocin for Induction of Labor in Patients With BMI > 30: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06259097
Acronym
BLOOM
Enrollment
303
Registered
2024-02-14
Start date
2024-07-02
Completion date
2026-08-10
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor, Pregnancy

Brief summary

This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.

Detailed description

This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.

Interventions

DRUGMisoprostol

25 mcg vaginally every 6 hours

3-6 mL intravenously every hour

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER
Bronx Care Health System
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30

Exclusion criteria

\- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30

Design outcomes

Primary

MeasureTime frameDescription
Time from induction to deliverystart of induction until deliverySimple measure calculating time from start of induction until delivery of neonate.

Secondary

MeasureTime frameDescription
Delivery outcomeat deliverySimple determination whether patient had a vaginal delivery or delivered by cesarean section.

Countries

United States

Contacts

STUDY_DIRECTORNicola F Tavella, MPH

Icahn School of Medicine at Mount Sinai

PRINCIPAL_INVESTIGATORAngela Bianco, MD

Icahn School of Medicine at Mount Sinai

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026